View Document Preview and Link Document Date: 2013-03-17 23:46:27 Open Document File Size: 248,23 KB Share Result on Facebook
City Holt / Leeds / / Company Cochrane Schizophrenia Group / Darling HF. / Johnson AE / / Country United States / Syria / Australia / United Kingdom / / / Facility University of Leeds / Arch Gen Psychiatry / Damascus University / The Cochrane Library / Cochrane Library / A depot / / MedicalCondition insomnia / DF / schizophrenia / Disease / parkinsonism / hallucinations / chronic / dyskinesia / tremor / orthostatic hypotension / non-affective serious/chronic mental illness / psychotic illness / neuroleptic malignant syndrome / restlessness / dystonia / dizziness / illness / rash / tardive dyskinesia / akathisia / / Organization World Health Organisation / Faculty of Medicine / World Health Organization / Damascus University / University of Leeds / Academic Unit of Psychiatry and Behavioural Sciences / / Person Tessa Grant / Clark Goldberg Hordern / Ana María / Din Matar / Judith Wright / Neuroleptic / Muhammad Qutayba / Hosam El-Din Matar / / Position King / coordinator / General / judge / / Product fluphenazine / pseudo / haloperidol / fluphenazine hydrochloride / F 15 / fluphenazine decanoate / prolixin / / ProvinceOrState Newfoundland / / PublishedMedium British Journal of Psychiatry / Archives of General Psychiatry / American Journal of Psychiatry / / Technology alpha / pdf / CGI / / URL http / SocialTag 
Artículos originales Oral fluphenazine versus placebo for schizophrenia: a Cochrane systematic review of 40 years of randomised controlled trials